POPULARITY
6 episodes with Rick Doblin
13 episodes with Rick Doblin
12 episodes with Rick Doblin
13 episodes with Rick Doblin
12 episodes with Rick Doblin
4 episodes with Rick Doblin
3 episodes with Rick Doblin
4 episodes with Rick Doblin
3 episodes with Rick Doblin
4 episodes with Rick Doblin
17 episodes with Rick Doblin
5 episodes with Rick Doblin
5 episodes with Rick Doblin
2 episodes with Rick Doblin
4 episodes with Rick Doblin
2 episodes with Rick Doblin
2 episodes with Rick Doblin
5 episodes with Rick Doblin
8 episodes with Rick Doblin
2 episodes with Rick Doblin
4 episodes with Rick Doblin
2 episodes with Rick Doblin
3 episodes with Rick Doblin
8 episodes with Rick Doblin
3 episodes with Rick Doblin
4 episodes with Rick Doblin
2 episodes with Rick Doblin
In this interview from 1977, Ram Dass shares his views on psychedelics and how they can provide a free slate to experience the innocence of consciousness once again. Join the most important psychedelic gathering of the year......bridging science, spirit & society at Psychedelic Science 2025: THE INTEGRATION, hosted by the Multidisciplinary Association for Psychedelic Studies. Be part of the movement that will shape the next era of mental health, medicine, and consciousness.Featuring speakers like Paul Stamets, United States Representative Tim Ryan, UCSF Neuroscience & Psychopharmacology Researcher Robin Carhartt-Harris, Rick Doblin, founder of Internal Family Systems (IFS) Richard Schwartz, Pilar Guzman, CEO/Medical Director of the American Psychiatric Association Marketa M. Wills - M.D., M.B.A., FAPA, Raghu Markus, comedian Reggie Watts, musicians TYCHO & Jim James, and many more!Listeners get 15% off tickets to the 5-day event with our promo code LSRF15 at PsychedelicScience.orgThis episode of Here and Now is from an interview with Ram Dass conducted by New Dimensions Radio in 1977, shortly after Ram Dass participated in a conference called “LSD – A Generation Later.” The interview begins with Ram Dass discussing the happenings at the conference and his interactions with other psychedelic luminaries, including Timothy Leary, Ralph Metzner, and Albert Hofmann. Ram Dass explores the culture surrounding LSD in 1977, and how he has no desire to legislate how other people live their lives. He shares his guru's instructions for using the “yogi medicine” and talks about whether or not it's important to have a guide for psychedelic experiences.Finally, Ram Dass cautions that “getting high and seeing” is only one part of the process of change, and there are inner processes necessary to bring about change in life. He discusses the cultural evolution brought about by psychedelics and the shifts in consciousness he sees taking place. The Ram Dass community gathers regularly to engage in meaningful discussions about the podcast. We invite you to join us and share your curiosities, insights, and wisdom. Sign up for the General Fellowship to receive event invitations directly in your inbox.Sponsors of this Episode:This show is sponsored by Magic Mind, a matcha-based energy shot infused with nootropics and adaptogens designed to crush procrastination, brain fog, & fatigue. Check out their new Maxx & Free energy shots and get 60% off your subscription with our code RAMDASS60 at magicmind.com/ramdassmfRam Dass Here & Now is also brought to you by BetterHelp. Give online therapy a try at betterhelp.com/ramdass and get on your way to being your best self.Reunion is offering $250 off any stay to the Love, Serve, Remember community. Simply use the code BeHere250 when booking. Disconnect from the world so you can reconnect with yourself at Reunion. Hotel | www.reunionhotelandwellness.com Retreats | www.reunionexperience.org“If you have a guide, you're calm, and you really want to explore your inner being, I still see LSD as an incredible vehicle for overriding your habitual response patterns, your habits of thought, and giving you a free slate to experience your innocence of consciousness once again.” – Ram DassSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Christina Kantzavelos is a neurodivergent, and first-generation (third culture) Licensed Clinical Social Worker (LCSW), life coach, writer and chronic illness warrior. She received both her BA and MSW from the University of California Los Angeles (UCLA) and her MLIS from San Jose State University (SJSU). She specializes in treating clients with chronic health conditions (aka spoonies and medical refugees) and trauma (including medical trauma). Rick Doblin, Ph.D., is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard's Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients.His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary's Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner.His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and puppy, with three empty rooms from his children who have all graduated college and begun their life journeys. Learn more about Rick by listening to his Origin Story, watching his TED Talk, and watching his SSDP talk about lessons for political activism from a series of his psychedelic experiences. In This EpisodeChristina's websiteNeural Retraining informationConstructed AwarenessRick's InstagramMAPS WebsiteYou can learn more about what I do here:The Trauma Therapist Newsletter: celebrates the people and voices in the mental health profession. And it's free! Check it out here: https://bit.ly/4jGBeSaThe Trauma Therapist Podcast: I interview thought-leaders in the fields of trauma, mindfulness, addiction and yoga such as Peter Levine, Pat Ogden, Bessel van der Kolk and Bruce Perry. https://bit.ly/3VRNy8zBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-trauma-therapist--5739761/support.
Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit established in 1986 to advance evidence-based psychedelic therapy and end prohibition. MAPS incubated Lykos Therapeutics (formerly MAPS Public Benefit Corporation) which is leading drug development of MDMA-assisted therapy for PTSD. Learn more about Psychedelic Science 2025, June 16–20 at the Colorado Convention Center in Denver, at www.psychedelicscience.org, and visit www.maps.org for information on MAPS Learn more about your ad choices. Visit podcastchoices.com/adchoices
This podcast comes from the Aspen Psychedelic Symposium from last summer. It features Diane Goldstein who is the executive director of Law Enforcement Action Partnership, Sarko Gergerian a police officer from Winthrop, Mass and Rick Doblin from MAPS. This panel was introduced by Zach Leary and was a highlight of our trip to Aspen's conference last year. We discuss new ways in which police should or could consider psychedelics and drugs more generally. Thanks to Aspen Public Radio and Aspen Psychedelic Symposium for allowing us to share this podcast.
Episode SummaryThe highly informed and deeply compassionate Amy Emerson joins Jef Szi and the How Humans Work Podcast for a remarkable conversation about the evolving landscape of psychedelics. With her extensive involvement and leadership in the Multidisciplinary Association of Psychedelic Studies (MAPS)* and their multi-year effort to get MDMA approved by FDA as a therapeutic medicine for PTSD. There are few better than Amy who can speak to the state of psychedelics for medical use in society. Not only does Amy share her honest appraisal about FDA drug approval process and members of congress on the Hill, she gives us the little known and fascinating history of MDMA. Some highlights are Sasha and Ann Shulgin's groundbreaking contributions, the reputational damage MDMA suffered in the 90's, the long-game efforts of Rick Doblin and others, the powerful way MDMA works on the brain, and the remarkable promise MDMA has shown to help people suffering with PTSD. Put together as a whole, Emerson offers us a destigmatized and inspiring view of MDMA beyond the common street descriptions of Ecstasy and Molly. From MDMA and the Medical Model, Amy then helps us see the many other use-cases for psychedelics that have a long and varied history. Building on issues of trauma and the importance of spiritually reconnecting with ourselves, we walk through the psychological benefits that can come with right-use of psychedelics.Finally, this conversation opens the visions of what future of psychedelic use in society through thoughtful contexts that track safety concerns and how, much like meditation, these ‘medicines' can have a place in our society like Buddhist and meditation practices have entered our culture. All in all, Breaking the Stigma is a podcast of significance, as it invites us to reconsider our biases around psychedelics at a time when our society is challenged by mental health matters like trauma and the pervasive disconnection from nature and spiritual renewal. ***** About: Amy Emerson is a highly respected leader in the field of psychedelic-assisted therapy. She was Lykos Therapeutics (formerly MAPS PBC) CEO for an important period in advancing MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) as a drug with the FDAShe earned a Bachelor of Science in Genetics and Cell Biology from Washington State University and spent the early career involved in roles at pharmaceutical companies, where she contributed to the development of therapies in immunology, oncology, and vaccines .In 2003, she began volunteering with the Multidisciplinary Association for Psychedelic Studies (MAPS), assisting with clinical research monitoring. Her expertise was instrumental in establishing MAPS' clinical department and managing the MDMA Clinical Development Program. When MAPS founded its Public Benefit Corporation (MAPS PBC) in 2014 to develop and commercialize MDMA-assisted therapy, Emerson was appointed CEO .Under her leadership, the organization, later rebranded as Lykos Therapeutics, completed multiple Phase 2 and Phase 3 clinical trials and raised approximately $150 million in funding. The company grew to over 120 employees, all working toward the goal of obtaining FDA approval for MDMA-assisted therapy for PTSD .Amy resigned form her CEO role in September 2024. Currently she is a senior advisor to Lykos and an independent psychedelic research consultant, awaiting the next big adventure.*****Chapters00:00 Introduction and Setting the Stage02:40 The Evolution of Psychedelic Research06:10 Understanding Stigma and Its Origins10:54 MDMA: From Therapy to Recreation16:33 Therapeutic Applications of MDMA20:28 Navigating the FDA and Drug Development24:45 Challenges
Word Up podcast favorite and psychedelic scholar, Robert Forte, returned to the podcast to talk about the Kennedy family legacy, JFK's history with psychedelics and the impending possibly, maybe confirmation of one RFK into the Department of Health and Human Services.Part 2:danikatz.locals.comwww.patreon.com/danikatzAll things Dani, including books, courses, webinars and coaching:www.danikatz.comRegister for Confluence (with Promo code KATZ10):https://brushfire.com/confluence/Confluence2025/590269Find Robert:www.alteredstatesofamerica.netalteredstatesofmaerica.substack.comtwitter.com/divinecomedy56Show notes:Forte's new book pending Is Trump a ‘new administration'? JFK, Zapruder, and official narrative2024 Election & propaganda Assassination attempt- real or fake?Plato's cave allegoryConfronting cognitive dissonance with dialogueBuddhism- 4 noble truths & last mealWhat is our role in other's lives and suffering?Psychedelic community movements & psy-opsNature of non-conformistsAssassination of JFKForte and The Kennedy's- hope & RFK RFK- good or bad faith actorAntonio Gracias & Rick Doblin- follow the moneyThe need for and naïveté of ‘hope'Political climate in GreeceTo write or not to write and make olive oilThe JFK files and suppressionThe alien & UFO psyopTrump, FDA, and psychedelicsTrump as CEO of America Corp
Il 144° episodio di Illuminismo Psichedelico - andato in scena al Magazzino Parallelo di Cesena il 24 gennaio 2025 - è stato più affollato del solito, oltre a me c'erano la psicoterapeuta Sara Ballotti, lo psicologo Michele Metelli e la facilitatrice di Respirazione Olotropica Alessandra Spagnoli, entrambi fondatori di Holotropic Italy. Durante la puntata abbiamo parlato degli effetti e del tipo di lavoro che svolge l'MDMA in assetto terapeutico, grazie a osservazioni, esperienze e ricerche svolte all'estero dai tre ospiti. Sono trent'anni che si studia l'MDMA come cura per la sindrome da stress post traumatico – qualche puntata fa intervistai il fondatore di MAPS, Rick Doblin – ma mi pare che in Italia raramente si sia provati a entrare nel merito di cosa succede e come funziona una terapia assistita con MDMA, proviamo a farlo in questa puntata.
Dr. Rick Doblin, founder of Multidisciplinary Association for Psychedelic Studies (MAPS), and Jeff Zucker discuss activism, psychedelics, epigenetics, generational trauma, and more. Watch this episode on YouTube https://youtu.be/xlsVDPRvDtE Chapters: 0:00 - Intro 2:34 - People are the Answer 4:37 - Put it Into Practice 5:56 - Intention 10:24 - Fear and Motivation 12:05 - What Motivates You? 19:45 - How Relatives Coped with the Holocaust 24:36 - Epigenetics of Trauma 26:29 - Giving Back in Early Life 33:43 - Global Spirituality 39:49 - What Lead to Starting MAPS? 52:44 - How Do We Move Forward with MDMA? 57:08 - State Level an Option? 1:00:28 - MAPS Cannabis Project 1:02:18 - Medical Cannabis in SC 1:05:02 - How Do You Avoid Burnout? 1:07:18 - What is MAPS Working on Now? 1:11:04 - Oregon Recriminalization 1:13:17 - Snap Your Fingers 1:15:26 - How to Support Rick Doblin: https://www.linkedin.com/in/rickdoblin/ https://www.instagram.com/rickdoblinphd/ MAPS: https://maps.org/ https://www.linkedin.com/company/mapsnews/ https://www.instagram.com/maps__org/ https://www.facebook.com/mapsmdma https://twitter.com/MAPS https://www.youtube.com/c/mapsmdma https://www.reddit.com/user/MAPSPsychedelic/?rdt=36196 Host: Jeffrey M. Zucker Producer: Kait Grey Editor: Nick Case Recording date: 12/3/24
Ospite della 131° puntata di Illuminismo Psichedelico è Rick Doblin, fondatore e presidente della Multidisciplinary Association for Psychedelic Studies (MAPS) ed ex membro del consiglio di amministrazione di Lykos Therapeutics. Insieme a Doblin abbiamo parlato della sua scoperta e del suo rapporto con l'MDMA, di come questo abbia ispirato la nascita di MAPS e le ricerche per consentire un uso terapeutico della sostanza, ma anche di come poi le cose siano andate male, a causa della concorrenza di altre entità che chiedevano fondi per ricerche sugli psichedelici MAPS è stata costretta a generare una costola "for profit", Lykos, che ben presto è diventata un "lupo tra i lupi", e Doblin ha deciso di lasciarla, mostrandosi molto critico con come la nuova entità ha scelto di comunicare ma anche di difendere i risultati della fase 3 dei trial sull'MDMA, bocciati nella scorsa estate dalla FDA.
In this episode, Joe interviews Rick Doblin, Ph.D.: founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), and former board member at Lykos Therapeutics, MAPS' public benefit subsidiary. Doblin tells his side of the story: that the FDA's concerns with double blinding not working had been fully addressed ahead of time, that they had negotiated agreements that were no longer agreed to when new FDA employees came on board, that there was a lot of confusion from going back and forth with the FDA on how Phase 3 studies should be designed, and more. He believes that Lykos made a massive mistake in assuming that provable science was more important than public opinion, and that ignoring critics who were saying whatever they wanted caused them to lose control of the narrative – which clearly influenced the advisory committee. While Lykos figures out their next steps with the FDA, MAPS is focusing their attention on what they feel is most important in light of this ruling: better public education and drug policy. He talks about: How there's a bias at the FDA to be harsh: Does automatically saying no just make it look like you're being rigorous? The work of the Dutch government in researching MDMA, and Lykos' odd decision to not highlight any of it Massachusetts' Legalization and Regulation of Psychedelic Substances initiative, and the huge opportunity for progress at the local level Why federal agents at Burning Man work so hard to give tickets to attendees for smoking cannabis Why sharing stories of your positive experiences with psychedelics is so important and more! MAPS has announced that 2025's Psychedelic Science conference will be in Denver, June 16-20, and will have experiential opportunities before and after. For links, head to the show notes page.
Psychedelic scholar, Robert Forte, returned to the podcast to FINALLY set the record straight on MDMA, MAPS and the FDA's recent (and salient) decision to not approve Rick Doblin's MDMA trauma therapy proposal, which the fake alt media community would have us believing is some sort of travesty. Oy.Part 2:danikatz.locals.comwww.patreon.com/danikatzwww.danikatz.comFind Robert:Twitter: @divinecomedy56https://www.alteredstatesofamerica.net/https://alteredstatesofamerica.substack.com/Show notes:Returning to the USA from GreeceSetting the record straight: MDMA, MAPS & the FDARFK & drug policy advisoryUpholding “The Narrative”: Joe Rogan, Aubrey Marcus, Jordan PetersonPsychedelic field researchersOrigins of Forte's MDMA journeyUS Neo-Conservatism & TotalitarianismTimothy Leary and Frank BaronConference of 1981 and Esalen InstituteHunter S. ThompsonDoblin- Secret snitch to Drug Guru and media darling“Conspiracy theorist” label vs real drug-related conspiraciesAmanda Fielding, Rebel Wisdom, ConspiritualityBooks: CIA, drug trade conspiraciesWWII: OSS members to Harvard professors/CIATimothy Leary: 1948 CIA funded MKUltraOperation Paperclip- Nazi's into USAAmerican Spirit diluted with drug psyops40's-50's psychedelic researchLeary- flawed character with anti-authoritarian spirit1985- Forte at U of Chicago- religion studyCharles Schuster & MDMA brain damageSchedule 1 drug & most popular drug in the worldEcstasy & Rave movement- drug deployment psychological warfareSalon article: art students, Mossad spies, DEA & drug ringsRick Doblin- questionable credentialsHeseg Foundation- “greatest moment of his life”Disclaimer- re Israel‘Orphan drug'- MDMA has no owner/no $ for PharmaAlex Shulgin- Bohemian GroveHuxley- Soma for the masses1984- MAPS (scam) launched- non-profit to $15kLeonard Pickard- DIA, LSD, & MDMAWhere is MAPS now?1970=Controlled Substance Act$16 million grant at Harvard for psychedelic researchBring MDMA back to consciousness explorationBill Maher and story-tellingAltered States of America and psychedelic movements
In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Alli Schaper, CEO and Co-Founder of SuperMush & The Microdosing Collective. Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-267-alli-schaper/?ref=278 Alli shares her journey from corporate America to becoming a leader in the functional and psychedelic mushroom space. They discuss the importance of microdosing, the challenges of psychedelic policy reform, and the mission of the Microdosing Collective. Alli emphasizes the potential of microdosing to enhance mental health, increase empathy, and create positive societal change. The conversation covers personal experiences, the need for consumer protection in the underground market, and the vision for making microdosing legally accessible. Alli Schaper is the CEO and co-founder of SuperMush, an LA-based mental wellness lifestyle brand. She is a speaker, entrepreneur, podcast host, educator, and community builder. She has been featured in Forbes 30 under 30, National Geographic, YPO, Summit Series, Well+Good, Rolling Stone, Goop, Bloomberg and more. Alli is a sought after thought leader on topics like mental health, functional mushrooms, microdosing, psychedelic policy, and building a better relationship with death. Alli's mission is to help make the world more colorful and fun and help wake people up by getting their brains and bodies off pharmaceuticals, and back into balance through the power of fungi. SuperMush has been called “The Redbull of Mushrooms”, and in just 2 years has grown into a multi-million dollar empire, built a viral 400k following across social channels, hosted 75+ IRL events across the U.S., and is backed by founders of Thrive Market, Netflix, Hu, Zumba, and more. She is also the host of SuperMush's popular mental health podcast, Into The Multiverse. Guests are globally-acclaimed artists, creatives, doctors, therapists, and leaders across wellness, mental health, consciousness, and psychedelics (previous guests: Rick Doblin, Gabby Reece, Charlotte McKinney, Devon Levesque, Noah Cyrus). Her passion for public policy and bringing microdosing psychedelics mainstream led her to co-found Microdosing Collective, the first nonprofit in the US focused on legal advocacy for microdosing. Highlights: Mushrooms and death Alli's journey from corporate America to psychedelic advocacy SuperMush and Into the Multiverse Microdosing Collective Challenges and experiences in psychedelic policy reform Vision for legal microdosing access and its potential societal impact The power of personal stories in advancing psychedelic policy How to get involved and support the Microdosing Collective Episode Sponsors: KA! Empathogenics Kanna Supplements. Get 10% off with code THIRDWAVE at checkout
Dr. Richard Miller is my special guest tonight to discuss how top researchers were carrying out experiments with psychedelic drugs under the direction of the government. Embracing the revival of psychedelic research and the discovery of new therapeutic uses, clinical psychologist Dr. Richard Louis Miller discusses what is happening today in psychedelic medicine--and what will happen in the future--with top researchers and thinkers in this field, including Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker. Dr. Miller and his contributors cover the tumultuous history of early psychedelic research brought to a halt 50 years ago by the U.S. government as well as offering non-technical summaries of the most recent studies with MDMA, psilocybin, LSD, and ayahuasca. They explore the biochemistry of consciousness and the use of psychedelics for self-discovery and healing. They discuss the use of psilocybin for releasing fear in the terminally ill and the potential for MDMA-assisted psychotherapy in the treatment of PTSD. They examine Dr. Charles Grob's research on the indigenous use and therapeutic properties of ayahuasca and Dr. Gabor Mate's attempt to transport this plant medicine to a clinical setting with the help of Canada's Department of National Health. Dr. Miller and his contributors explore the ongoing efforts to restore psychedelic therapies to the health field, the growing threat of overmedication by the pharmaceutical industry, and the links between psychiatric drugs and mental illness. They also discuss the newly shifting political climate and the push for new research, offering hope for an end to the War on Drugs and a potential renaissance of research into psychedelic medicines around the world.Follow Our Other ShowsFollow UFO WitnessesFollow Crime Watch WeeklyFollow Paranormal FearsFollow Seven: Disturbing Chronicle StoriesJoin our Patreon for ad-free listening and more bonus content.Follow us on Instagram @mysteriousradioFollow us on TikTok mysteriousradioTikTok Follow us on Twitter @mysteriousradio Follow us on Pinterest pinterest.com/mysteriousradio Like us on Facebook Facebook.com/mysteriousradio
In this episode, Joe interviews Joanna Kempner, Ph.D.: associate professor in the Department of Sociology at Rutgers University and author of the recently released, Psychedelic Outlaws: The Movement Revolutionizing Modern Medicine. The book profiles the history and groundbreaking work of ClusterBusters, a nonprofit researching and spreading awareness about what someone named Flash discovered decades ago: that for some people, psilocybin and LSD could stop cluster headaches from coming on. Through early internet message board posts and email exchanges between Bob Wold, Rick Doblin, and others, Kempner pieced together their story. And through attending ClusterBusters meetings, she discovered that a lot of the true healing lies in the bonds formed and the hope people find when seeing something new work for a pain for which science has no answer. She discusses: The lack of political will behind something so debilitating: Why is there no funding for this? The importance of patient advocacy and the role of the internet in sharing novel information The difficulty in studying a disease so unpredictable: How do you run a randomized trial when you don't know when a cluster is going to happen? Why the headache community clashes with psychology Concerns over how to ethically combine underground and Indigenous knowledge with above-ground University research and more! For links, head to the show notes page.
In this episode of Psychedelic Divas, the multi-talented Dream Mullick shares her diverse experiences and insights spanning writing, teaching, producing, and death coaching. Dream shares her journey from co-producing the Psychedelic Integration Conference at Esalen to her upcoming documentary on Rick Doblin's mission to legalize MDMA. Our conversation touches on psychedelic experiences, their impact on trauma, the significance of sacred ceremonies, and Dream's personal encounters with death, grief and near-death experiences. Dream offers practical advice on integrating ceremony into everyday life and underscores the importance of safely navigating psychedelic journeys. https://www.dreammullick.com/ https://entheowheel.com https://whatatrip.film RECEIVE YOUR FREE GUIDE: “PSYCHEDELIC SAFETY TIPS INCLUDING WHAT TO DO WHEN THINGS GO WRONG: https://psychedelicdivas.com/
Chemistry professor Dr. Joey Lichter, breaks down how psychedelics work, the supreme importance of integration, the history of psychedelics, and the potential problems we will face as these misunderstood medicines are integrated into the mainstream medical model. Dr. Joey Lichter Show Notes: We discuss; -Started Psychedelic Club in 2021 [5:00] -Hype & Hope vs True Evidence [6:50] -Microdosing and creativity [9:00] -Dr. Joey Lichter's inspiration and motivation to serve [11:55} -Will MDMA-assisted therapy for PTSD be approved by the FDA in August? [23:30] -Trip of Compassion [26:00] -Our broken medical system [29:00] -Risk of over-dependence on medicine [35:55] -Psychedelics, meditation, and our breath [39:30] -Brain chemistry: how psychedelics work [42:00] Connect with Dr. Joey Lichter: https://www.linkedin.com/in/joseph-lichter/
Rick Doblin, Ph.D., is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard's Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary's Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and puppy, with three empty rooms from his children who have all graduated college and begun their life journeys. Learn more about Rick by listening to his Origin Story and watching his TED Talk.
Why did an FDA panel recently decisively reject MDMA for medical use despite some supportive scientific studies? Join us on the TDR podcast as we grapple with this critical and controversial topic alongside our distinguished guest, Kevin Sabet. In this episode, we unpack the intricate history and ambitions of MAPS, the organization led by Rick Doblin, which transformed into the for-profit Lycos Therapeutics. Kevin offers his expertise on the mixed results from rigorous studies submitted to the FDA and the factors behind the panel's overwhelming vote against MDMA for treating PTSD. This discussion sheds light on the broader implications for psychedelic therapies and FDA regulations.We also delve into the media frenzy and the optimistic anticipation within the psychedelics advocacy community leading up to the panel's decision. Despite the buzz and support from certain quarters, the committee's vote of 10 to 1 against MDMA underscores the complexities and risks associated with approving psychedelics for medical use. Get ready for a comprehensive analysis of this pivotal decision and its potential impact on the future landscape of PTSD treatments. Tune in for valuable insights on what lies ahead for MDMA in therapeutic settings and the FDA's ultimate stance.Follow the work of SAM and FDPS below:https://learnaboutsam.org/https://gooddrugpolicy.org/https://thedrugreport.org/On X: https://twitter.com/learnaboutsamhttps://twitter.com/GoodDrugPolicyhttps://twitter.com/KevinSabethttps://twitter.com/LukeNiforatosOn Facebook: https://www.facebook.com/learnaboutsam
Victoria Litman is a law professor and a nonprofit tax attorney focused on the emerging cannabis and psychedelic tax-exempt sectors. In addition to her legal credentials, she also holds degrees in Religion from the University of Southern California and a Master of Divinity from Union Theological Seminary where her concentration was Religion and Law. Victoria received her J.D. from New York Law School, cum laude, and her LL.M. In Taxation from Georgetown University Law Center with distinction. As a Graduate Tax Scholar at Georgetown, today's guest received a research fellowship to study the tax approaches taken by religious communities that utilize psychedelics. Victoria also teaches Cannabis Law at Roger Williams University School of Law and Tax Practice and Procedure at Suffolk Law School. Her legal scholarship focuses on the intersections of constitutional law, tax law, and drug law with a focus on issues of religious freedom.Joyce also speaks with Cassie Lemon founder of Let's Jam – a canna jam company that spreads a little love and comfort in every jar. Culture Corner:One Life starring Anthony Hopkins. Based on the true story of a British man who helped save over 600 children – mostly Jewish - escape Prague right before the Nazi invasion in 1939. A truly moving story and timely given the rise in hate around the world. It is a story about why each one of us has the power to help others and that we may never understand the impact we have on this world with acts of kindness. The One Life movie is about an ordinary man who found out over 40 years later how impactful his actions were in saving those children. Apple TV, Palm Royale starring Kristin Wig, Laura Dern, Allison Jenny and Ricky Martin, and Carol Burnet, so many great actors. Truly star studded. A campy story of Palm Beach Florida in the 1960's, it can be cringy and serious and the clothes are fantastic. And Ricky Martin is so good and still so cute. Palm Royale.Topics Discussed(1:00) Welcome(1:10) Canna Shortage on Martha's Vineyard and Nantucket!(2:20) Green Lady Dispensary podcast episode(3:25) Seniors and Cannabis Trouble(4:20) Cannabis NOT a Poison(5:40) Let's Jam(5:50) The Culture Corner(6:10) One Life(8:40) Palm Royale(10:45) Victoria Litman Introduction(12:55) Religion and Law(14:05) What She's Working on Now(14:39) Linked-In Connection(15:00) Tax and Churches(16:10) Personal Canna History(17:55) Canna Stigma Beliefs(18:40) Grandma Story(19:20) MAPS and Rick Doblin(20:14) Breaking Stoner Stereotypes(21:00) Psychedelics and Churches(24:10) How to Balance Use of Psychedelic Therapies(26:10) Why Should Psychedelics Be Legal(27:30) Rescheduling Cannabis(30:50) Why More Needs to Done by Congress(31:35) Special Segment Guest: Cassie Lemon and Let's Jam(33:17) How Cassie's Mom Used Canna Jam(36:10) Family Jam(37:08) Where Do Find Let's Jam – Official Let's Jam(38:25) Back with Victoria(38:40) Jews in Weed(41:00) Tokin' Jew(43:00) Lehrhaus House(44:10) Rhode Island Psychedelics and Cannabis(47:00) Power of Psychedelics(48:40) Favorite Way to Consume(49:05) Connect with Victoria on Linked-In by email The Canna Mom Show wants to thank:Josh Lamkin and Bella Jaffe for writing and performing TCMS theme music and Fortuna Design for creating TCMS website and Sugar Leaf Creative for marketing and social media.
The U.S. Food and Drug Administration is reviewing MDMA-assisted therapy for post-traumatic stress disorder, which could become the first psychedelic-assisted therapy as early as August. Today, The Common presents the final episode of our three-part series looking at the past, present and future of psychedelics in Massachusetts as a potential ballot question that could lead to the decriminalization of natural psychedelic substances in Massachusetts. Rick Doblin, founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), is featured in today's conversation. He has led efforts to bring psychedelics back into mainstream medicine, in part by organizing clinical drug trials to get MDMA-assisted therapy for PTSD approved by the FDA. Greater Boston's daily podcast where news and culture meet.
Dr. Matthew Johnson joins Whiz for an explosive podcast covering some of the recent controversy in the psychedelic space surrounding clinical trials and potential bias. Dr. Johnson and Whiz met a couple years ago speaking at the Psychedelic Medicine Coalition along with Tim Ferris and Rick Doblin. Dr. Johnson is one of the world's leading and most published scientists on the human effects of psychedelics and has conducted seminal research in the behavioral economics of drug use, addiction, and risk behavior. Dr. Johnson led critical research at Johns Hopkins, along with Dr. Roland Griffiths, into the healing potential of psilocybin. He and Whiz dig dip into how personal bias can creep into studies, potentially impacting the outcome, when it's not needed to impact positive results. They also discuss how negative results can only help the cause by having an open and honest debate about data, not feelings. BYOB – bring your own Budda if you want – but don't be steered by researchers. Whiz shares how God, religion and spirituality were not part of his ‘pre-trip' prep, but that was the result he experienced.
Rick Doblin is the founder of MAPS (multidisciplinary association for psychodelic studies), which just complete phase 3 trials for using MDMA to treat PTSD. They have an astounding success rate curing PTSD with 67% and addition 21% seeing good progress towards healing... thats 88% success in helping people live better lives. https://www.maps.org
Rick Doblin, founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), chats with Trey Elling. Topics include the potential medicinal benefits of... Intro (0:00) Cannabis (2:16) MDMA (9:55) Ibogaine (24:56) Psilocybin (31:56) Qualified psychedelic therapists (37:32) Total eclipses (42:39)
David, the Cosmic Engagement Officer of the Dr. Bronners Soap Company, walks the talk and truly lives aligned with the psychedelic principles of love, peace, and unity. He shares his soulful transformation and the All-One Cosmic Vision of the more beautiful world our hearts know is possible. I'm wowed by David's unrelenting spirit of altruism and his heartfelt commitment to selfless service and paying forward the grace of plant medicine healing through conscious business, activism, drug policy reform, and psychedelic healing. Get ready to be inspired! David Bronner Show Notes We Discuss; -David Bronner's inspiration behind incredible service initiative [4:30] -Veteran healing: Heroic Hearts Project & VETS (Veterans Exploring Treatment Solutions) [13:30] -“Taking medicine is like going to confession.” [16:00] -David's cosmic vision: medicine path and medicine journeys with Iboga [18:15] -Ultimate antidote for addiction [27:30] -Dr. Bronner's conscious capitalism initiatives [35:00] -Drug reform on upcoming ballot in California & Massachusetts [39:30] -Regulated access and self-regulated communities [48:00] Helpful resources: Dr. Bronners: https://www.drbronner.com Heroic Hearts Project: https://heroicheartsproject.org VETS: https://vetsolutions.org Sacred Plant Alliance: https://www.sacredplantalliance.org Connect with David Bronner: IG: https://www.instagram.com/bronner64/ https://www.instagram.com/drbronner/
Rick Doblin, Ph.D., is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard's Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary's Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and puppy, with three empty rooms from his children who have all graduated college and begun their life journeys. Learn more about Rick by listening to his Origin Story and watching his TED Talk.MAPS Texas Eclipse InfoDonate to MAPS.orgThe JRE Episode that started it all.The Synergy of Medicine, Science, and Public Benefit.Lykos TherapeuticsBook: Zen and the Art of Motorcycle Maintenance
In today's episode of the Psychedelic Therapy Frontiers, the podcast, Dr. Steve Thayer and Dr. Reid Robison are joined by Rick Doblin, Ph.D. Rick is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). His tireless efforts over almost 40 years in both clinical research and public policy reform have played a key role in bringing psychedelic medicine to the very exciting point that it is now. They discuss the origin story behind MAPS, the existential crisis humanity is facing and the need for healing on a global scale, the potential FDA approval of MDMA-assisted therapy for PTSD, the “Fallen Mormon” study on the safety of MDMA, the “high bar” that should be set for therapists who work with psychedelic tools, whether or not those therapists should have their own psychedelic experiences as part of their training, and much more.https://maps.org/https://seetexaseclipse.com/Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/
Today’s episode is with Rick Doblin Ph.D., the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. He founded MAPS in 1986, and currently resides in Boston with his wife and puppy, with three empty rooms from his children who have all graduated college and begun their life journeys. Learn more about Rick by listening to his Origin Story and watching his TED Talk. We talk about the following and so much more: ✅ Why he thinks psychedelics and plant medicine are important? ✅ His perspective on the spiritual connection to plant medicine and psychedelics and whether there is a difference if it comes from nature or if it's from a lab ✅ What is MAPS, and what is the mission of MAPS? ✅ How he navigates the challenges of destigmatizing these substances and promoting their potential therapeutic benefits ✅What his thoughts are on the different types of psychedelics – and if there are any that he prefers for some scenarios over others ✅ His thoughts on your 2019 TED talk, “The future of psychedelic-assisted therapy” and if your perspective changed at all post-pandemic? ✅ The experiment on the use of ayahuasca / MDMA between Jews and Arabs, and what the outcome was like If you’d like to join the waitlist for my next coaching program, sign up @ www.InnerKnowingSchool.com Please tag us and tell us what you loved! You can follow @Gateways_To_Awakening on Instagram or Facebook if you’d like to stay connected.
Welcome back to The Trip Report Podcast, a production of Beckley Waves, a Psychedelic Venture Studio.Today, I am speaking with Rick Doblin, founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS).December of last year was a milestone for Doblin and MAPS, as the organization submitted a New Drug Application for MDMA Assisted Therapy to the United States Food and Drug Administration.Then, in the first week of January, the MAPS Public Benefit Corp announced its rebranding to Lykos Therapeutics and a $100 million Series A financing.Needless to say, it has been a pivotal period in the organization's history and a watershed moment for the revival of psychedelic medicine, science, and policy.In February, the FDA accepted the application and granted a priority review, putting the decision timeline at August of this year.That's just around the corner.And so much is still up in the air—of course the big question—will the FDA grant approval? But also so many granular details that will have significant downstream effects on the commercial rollout, access, and cost.* What language will be on the drug label? * What will the Risk Evaluation and Mitigation Strategy entail? * How will patients be able to access the drug? * What will the FDA say about the role of therapy?Among others.So, I wanted to sit down with Rick to talk about it and get his perspective on the organization's evolution, the path ahead, and, most importantly, the many uncertainties that hang in the balance.In this conversation, we discuss:* The importance of therapy in conjunction with MDMA (and his loathing of the acronym MDMA-AT)* The many regulatory and bureaucratic details that go into the FDA's decision and subsequent commercial rollout, including:* Drug labeling* Therapist credentialing * Risk Evaluation and Mitigation Strategies* The negotiations he's led with the FDA over the last 20 years* Lykos' goal of getting MDMA-Assisted Therapy FDA approved and MAPS' goal of getting MDMA federally legalized* The role of therapist's first-hand experience with MDMA and the regulatory battle of ensuring legal access to this group* His future humanitarian and scientific plansAnd much more.And now I bring you my conversation with Rick Doblin.Listen to the episode on Substack, Spotify, Google or Apple.Credits:* Hosted by Zach Haigney * Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari* Find us at thetripreport.com* Follow us on Instagram, Twitter, LinkedIn and YouTubeTheme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thetripreport.com
In this new podcast episode, Isra Garcia presents 18 interviews focused on the field of psychedelics; those interviews feature 18 different profiles with stories, experiences, advice and recommendations from a myriad of experts, specialists, therapists, scientists, researchers, and curious enthusiasts from the industry. This conversation was kept during the Psychedelic Science 2023 conference in Denver (Colorado), where MAPS invited Isra to cover the event as a Spanish podcaster focused on psychedelics, human potential and peak performance. "Integration is on the backend of things but is also preparing the mind, soul and body... Develop your relationship and integration practice with the medicine" - Jeremy Colbert. The topics range from Psychedelics therapy, ketamin protocols and psychedelic peer support to integration coaching, and more. "In 1994, I announced to friends of mine, while I was in Grade School getting a master's Degree in Psychology, that I would devote myself to psychedelic psycho-assisted therapy when the time was right; I have been watching this, and I jumped as I soon as I could" - Sandra Newes "The most ancient technology we have is community healing" - Teresa Ting. Index of contents - and what you will learn in this episode: Introduction and context. Kira: volunteering with MAPS, diversity, education and the science behind it. Jeremy Colbert: integration coaching, a combination of psilocybin and ayahuasca, skills and tools for integration, where science meets spirituality. Teresa Yung: psychedelics and trauma working for the community space; how can we hold it, how can bring it, healing through peer support and the pinnacle of humankind. Sandra Newes: putting all your purpose on psychedelics, an online community for psychedelics providers for mental health, works better than anything else I've tried, bringing together the clinical, the physical, the medical, the spiritual and the shamanic. Gino Wilkins: questioning the status quo, reflective work, learning from the mistakes from the past, setting structures to build a more mindful psychedelic landscape. Nadia Van der Heyden: COO at Alvarius, researching with 5-Me0-DMT, its dicoveries and its potential benefits for treating addictions and other disorders, a full circle healing experience, big takeaways from taking psychedelics personally, and best advice. Mattha Louis Busby: journaling and wiriting for psychedelics, being in the present moment, releasing tension, investigative elements with the experiential, psychedelics in the UK, the proper integration ceases more psychedelic usage. Ron King: researching on psychedelic medicine, on the making of a psychedelic movie, the psychedelic work that is going on, a new beggining. Steven Turetsky: Irya Mosina: Julián Amaro: Kecho: Charlie: Natalie: Lauren M Hodge: Dylan Higginbotham: Kevin Cranford: working at MAPS, the largest psychedelic conference gathering, creating a bigger impact, his personal story. What's your psychedelic story? And ending. "When I was younger my dad had to go to prision for working with psychedelics and it was a very painful process for the family.. But now, 20-25 years later, become full circle where the same government that put him in prision is now giving him the license to produce and manufacture this drugs for research" - Nadia Van Der Heyden. Podcast show notes and resources: MAPS. Rick Doblin Interview. Jeremy Colbert integration coach - Taragape Instagram. Lorna Liana Spirit School. Being True to You Transformation Coaching and Training. The Trauma Project. Psychedelic Provider Network. Sandra Newes. The Living Medicine Institue. Gino Wilkins Linkedin. Nadia Van der Heyden LinkedIn. Alvarius. Peter Van Der Heyden. Mattha Link.tr. Uncharted Territory podcast. Viztor Movie. Psychedelic Science, Therapy, Experience: 18 Stories around psychedelics, human potential and, holistic healing and mental health - Disrupt Everything podcast by Isra Garcia #248
"No dejes de buscar tu propio camino, repetar todo y agradecer todo para encontrar tus propias respuestas" - Natalia Algarín. En junio de 2023 Isra asistió al congreso Psychedelic Science 2023 organizado por MAPS, fue en Denver (Colorado). Isra fue previamente invitado por la Asociación Multidisciplinar de Estudios Psicodélicos (MAPS) como podcaster especializado para habla hispana y también como representante de Psilocibina Ciencia y Experiencia, plataforma divulgativa sobre psicodélicos. Durante estos días, Isra realizó diferentes entrevistas a expertos en el campo de los psicodélicos, pero además recogió historias y experiencias de algunos de los asistentes que iba encontrando. "España estuvo a punto de ser uno de los pioneros y referentes mundiales en el renacimiento psicodélicos allá por el año 2.000" - Antón Gómez Escolar. "Deja de lado lo que has escuchado o visto sobre los psicodélicos y fíjate en su evidencia en eficacia y seguridad" - Antón Gómez Escolar. En este podcast podrás encontrar el testimonio de 5 personas que cuentan su experiencia, perspectiva, motivaciones, propósito y enfoque sobre los psicodélicos. Una forma de proporcionar información para seguir acercando este tan desconocido y a veces malinterpretado y estigmatizado mundo de las sustancias psicodélicas. El propósito de Isra no es más que servir de puente para que cualquiera pueda conocer realmente qué está pasando en este renacer de los psicodélicos de la mano de los principales expertos y fuentes mundiales a los que el mismo Isra tiene acceso. "La medicina es algo muy importante para mí, pero en este momento de mi vida, la medicina que yo ejerzo no es suficiente para mí, creo que hay otros tipos de medicinas que son más importantes para sanar cuerpo y alma" - Elisabeth Fabián. Índice de contenidos y qué aprenderás en este episodio Introducción y contexto Adriana Correa: descubrimientos, atajos mentales, estudios, y psicodélicos para transformar la consciencia. Antón Gómez Escolar: psicodélicos 101, la Drogopedia, el renacimiento, estrategia, momentos estelares, el uso de los psicodélicos como medicamento aprobado, la psicoterapia con el uso asistido de psicodélicos, y la ignorancia sobre las drogas. Eduardo Pinto: cambiar la interpretación del dolor, los psicodélicos vs la fibromialgia y volver a sentir. Elisabeth Fabián: más allá de la cirugía y la medicina convencional, otras formas de sanar cuerpo y alma, el poder de las comunidades y los psicodélicos como medicina que apoya otro tipo de crecimiento más allá de curar síntomas, hábitos y habilidades que ayudan. Natalia Algarín: combinar lo que te salva la vida con lo que haces a diario, la psilocibina en uso personal contra la ansiedad y depresión, la disciplina como terapia, el neurofeedback, el orgullo de la familia y sentir el reto. Feedback y final. "Todos los que están aquí sentados, están arriesgando su reputación para salvar a otros con los psicodélicos" - Rick Perry, ex-gobernador de Texas. Notas y recursos del podcast "Atajos Mentales" - Adriana Correa podcast. Adriana Correa Instagram. Antón Gómez Escolar LinkedIn. Amanda Feilding. Guía Esencial del Renacimiento Psicodélico - libro. Rick Doblin entrevista. ICEERS. Alexander Shulgin. Robin Carhart-Harriss. La Drogopedia de Antón. Cómo Cambiar tu Mente - libro. Mujeres Psicodélicas - podcast. Eduardo Pinto LinkedIn. Elisabeth Fabian Instagram. Cristina Duncan - LinkedIn. El Neurofeedback. Natalia Algarín - X. "He pasado de dolor a no dolor, y a sentir, perdí a mis amigos, comencé a socializar, recuperé las relaciones con mis hijos, mi padre... Abran su mente un poco con los psicodélicos, investiguen, todos hemos sacado algo bueno, incluso teniendo un mal viaje" - Eduardo Pinto. Podcast Ciencia Psicodélica: 5 historias y experiencias de 5 personas sobre psicodélicos en Psychedelic Science 2023.
Break Through: Master Your Default Mode and Thrive by Hosein Kouros-Mehr https://amzn.to/4234lHv Yourdefaultmode.com "Break Through is a fascinating, science-backed exploration of the default mode network (DMN), considered to be the actual location of ‘self' in the brain. Understanding and healing our DMN is a promising way to tackle society's mental health epidemic.” - Rick Doblin, PhD, Founder of MAPS What's stopping you from being truly happy and at peace? Could it be your wandering mind that constantly revisits painful thoughts and bad habits? Scientists now have a name for the wandering mind—the default mode network (DMN), a barrier that can prevent you from enjoying life. Your DMN takes you away from the present moment and encourages you to ruminate on the past and future. This can lead to painful conditions—mental knots—like stress, anxiety, emotional pain, addiction, and depression. Fortunately, you can break through this wall to the blissful peace in your core. Backed by scientific data, Break Through connects the medical and spiritual realms on a journey of inner healing. With a holistic approach, you can master your default mode and rise to your best self. Unlock health, happiness, and inner peace, and open the door to new possibilities that you once deemed impossible.About the author Hosein Kouros-Mehr, MD, PhD is an author and physician-scientist who has spent over two decades in cancer research and drug development. Thanks to his background, Hosein recognized the extraordinary ramifications of a recent scientific discovery: the default mode network (DMN), which encodes the human ego and influences our thoughts, emotions, and behaviors. Recognizing the profound impact of this breakthrough on self-understanding (both from clinical and personal experience), he wrote "Break Through: Master Your Default Mode and Thrive" to help readers master the DMN and live happier, more fulfilling lives. Hosein is also the author of two futuristic novels, "Extinction 6" and "Project Bodi: Awaken the Power of Insight," that explore the inner workings of the mind. He lives in Los Angeles with his wife and children.
Today we are joined by psychedelic activist and founder of MAPS, Rick Doblin. In this conversation, Alli and Rick discuss the hopeful potential of bringing psychedelics to the masses for celebration, healing, and changing the world. Rick shares his personal insights from MDMA and LSD, reflecting on the fact of death and how realizing it's impermanence helped him live a better life. He shares how psychedelics can be used for heart-opening and healing PTSD. He and Alli discuss the process of legalization and the importance of languaging when it comes to speaking to the masses. He also shares the inspiring journey of founding MAPS and how the vision has expanded over time. === TIMESTAMPS: 0:00 Intro 2:32 Facing the Fact of Death 6:31 Rick's LSD Awakening to Life's Impermanence 20:23 The Essence of MDMA: Opening the Heart 33:28 Similarities of Meditation & MDMA 35:30 Using Psychedelics to Process Trauma in Real Time 49:56 Language Used in Psychedelic Policy 1:02:16 Speaking to the Masses Across Party Lines 1:16:00 The Journey of MAPS & What's Coming Next 1:34:06 Conscious Capitalism: Changing the Way We See Profit 1:41:00 “This Timeless Moment” Reflecting on Death 1:43:58 Rick's Most Important Lesson from Psychedelics 1:45:30 Conclusion === Rick Doblin: MAPS: https://maps.org Rick's Instagram: https://www.instagram.com/rickdoblinphd/ === Step into the Multiverse with us... Into the Multiverse Instagram: https://www.instagram.com/intothemultiverse/ https://supermush.com/ our in house brand of the most effective and delicious functional mushroom supplements. Super Mush Instagram: https://www.instagram.com/supermush/
Support Lorenzo on Patreon.com Guest speakers: Rick Doblin, Lester Grinspoon, Richard Yensen, Donna Dryer, Myron Stolaroff, Willis Harman, Ralph Abraham, and Robert Anton Wilson PROGRAM NOTES: Today's program features the continuation of Podcast 684, the Psychedelic Summit that was held in Santa Cruz in 1992. As you can tell from the list of speakers, it was another celebrity-packed speakers' list. While all of the names will be famaliar to you, this is the first time that we've had talks by Lester Grinspoon, Willis Harman and Robert Anton Wilson here in the salon. PSYCHEDELIC AGENTS IN CREATIVE PROBLEM-SOLVING: A PILOT STUDY (1966) The Issue of the Consciousness-Expanding Drugs - Willis Harman (1963)
Do psychedelics reveal a different objective reality? Neil deGrasse Tyson and Chuck Nice learn about psychedelic drugs, treating PTSD, and other mind-bending research with President of Multidisciplinary Association for Psychedelic Studies (MAPS) Rick Doblin.NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free.Thanks to our Patrons Mark Rosenthal, David Aulwes, Alissa Mc Cormick, Gavin Bamber, Lester Teichner, Chase Kimes, and Cindy Barrick for supporting us this week.Photo Credit: Storyblocks
In this episode, Kyle interviews Bessel van der Kolk, MD: pioneer clinician, researcher, and educator on traumatic stress; Founder of the Trauma Research Foundation; Professor of Psychiatry at Boston University Medical School; Principal Investigator of the Boston site of MAPS' MDMA-assisted psychotherapy study; and author of the #1 New York Times Science best seller, The Body Keeps the Score: Brain, Mind, and Body in the Treatment of Trauma. As of this recording, van der Kolk was publishing his last paper and closing down his laboratory, so he looks back on his past: being part of the group who put together the first PTSD diagnosis in the 80s; the early days of psychedelic research and how he discouraged Rick Doblin and Michael Mithoefer from pursuing MDMA research; how the DSM has no scientific validity and was never meant for the diagnosing it's being used for; how science wasn't seeing the whole picture and pushing us mindlessly from medication to medication; and how trauma research has evolved over the years as society learned more about how the mind actually works. He discusses the struggle to validate “softer” sciences; the impracticality and price of the MAPS protocol and the need for more group and sitter/experiencer frameworks; the efficacy of psychodrama and how that plays out in group sessions; his interest in using the Rorschach test more; how rolfing helped him; the problem with diagnosis and people becoming their illnesses; bodywork, somatic literacy, and how disconnected most people are from their bodies; and how, in all the healing frameworks he's explored, he has never seen anything work as profoundly as psychedelic-assisted therapy. Click here to head to the show notes page.
Support Lorenzo on Patreon.com Guest speakers: Matthew Brederick, Bruce Eisner, Rick Doblin, Oscar Jannigar, Albert Hofmann, Humphry Osmand, John Beresford, Laura Huxley, Francis Huxley PROGRAM NOTES: Today's podcasta features talks from the 1992 Psychedelic Summit that was held in Santa Cruz. As you can see from the names of the speakers, this was a star-studded event. While this 1992 conference features much talk about the War on Drugs, it is an interesting counterpoint to the conference that was held in Denver earlier this year in which the focus was the scientific importance of psychdelic substances.
Juliana is back to share her critically important work with Healing Breakthrough, where they are working earnestly to lay the groundwork within the Veteran Affairs (VA) for MDMA-Assisted Therapy, which is very likely to be an approved FDA cure for PTSD within the next year. We illuminate the incredible possibility within the veteran community to lead this charge and to be a desperately needed rallying point to unify our fractured nation and global human family. It's time to come together. Juliana Mercer Show Notes: We discuss; -Juliana's inspiring work with Healing Breakthrough [5:40] -MAPS Clinical Trials 71% no longer qualify for PTSD [7:00] -Veteran healing is bipartisan [10:45] -Power in vulnerability [15:30] -Juliana's self-care and integration practices [20:00] -Grieving her old self [26:30] -Netflix Boyscouts of America 82k plaintiffs of sexual molestation scandal [30:00] -Why veterans lead this charge [37:00] -Healing Breakthrough's strategy to scale MDMA-Assisted Therapy [41:10] -Only 15-20 private donors in the psychedelic space [49:00] Connect with Juliana Mercer: IG: https://www.instagram.com/xojmerc/ LinkedIn: https://www.linkedin.com/in/julianamercer/ Juliana@healingbreakthrough.org www.healingbreakthrough.org Helpful Resources: VA Podcast: https://news.va.gov/va-podcast-network/ Heroic Hearts Project: www.heroicheartsproject.org Magic of Surrender - Kute Blackson Connect with Matt Simpson: Worth The Fight Book: Kindle, Audiobook & Paperback www.worththefightbook.org IG @worththefightbook Meetup: https://www.meetup.com/psychedelics-and-limitless-personal-growth/ matt@nltrans.org
In this episode, Joe interviews Federico Seragnoli: coordinator of the ALPS Foundation, psychologist who works with patients undergoing compassionate use treatments with psychedelics, and Founder of the ALPS Conference. This year, the ALPS Conference (which stands for Awareness Lectures on Psychedelic Science) takes place Oct. 27 – 29 at the Bâtiment des Forces Motrices in Geneva – a prime location for a conference due to Switzerland's legality around psychedelics, where any citizen can apply for psilocybin or LSD therapy if they fall into the category of ‘treatment-resistant.' Seragnoli discusses how the conference was originally inspired by an article on the MAPS blog about how to be a psychedelic researcher; and talks about its humble beginnings, its new location, and why it's moved across the country each year. The conference features names like Rick Doblin and Michael Mithoefer, but he's most excited about the smaller size of the event and the panel discussions, which gives attendees a chance to ask questions and hear some real conversations. He discusses the vibrant field of psychedelic therapy and research in Switzerland; the importance of compassionate use and the criteria physicians need to be able to use it; the impact of students creating psychedelic associations at their universities; and Seragnoli's new research: seeing if there is a link between cognitive science and a conceptualization of science – if you can model consciousness off neuroscience, can you model it off how you feel? Click here to head to the show notes page.
In this episode, Joe interviews Deborah C. Mash, Ph.D.: neuroscientist; Professor Emerita of Neurology and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine; and leading researcher in addiction and brain disorders for over 30 years. She is also the CEO and Founder of DemeRx Inc., a clinical stage drug development company working to advance ibogaine and its active metabolite, noribogaine, for the treatment of opioid use disorder. She talks about the Federal and state complications behind ibogaine research, the need for partnerships between clinics and researchers, what needs to be done to collect much needed Phase II and III ibogaine data, and why this all has to be in partnership with the FDA. And she discusses much more: her story of how studying Cocaethylene led to her finding out about ibogaine; ibogaine and QTc-prolongation; deaths related to iboga and the amount of variables that aren't considered; how the French were essentially using noribogaine in the 1930s; and, as this was recorded at Psychedelic Science 2023, her thoughts on the event and Rick Doblin's opening statement. Click here to head to the show notes page.
For 37 years, Rick Doblin has been pushing the F.D.A. to approve treating post-traumatic stress disorder with MDMA, better known as Ecstasy. He tells Steve why he persisted for so long, why he doesn't like calling drug use “recreational,” and what he learned from his pet wolf. RESOURCES:"MDMA-Assisted Therapy for Moderate to Severe PTSD: A Randomized, Placebo-Controlled Phase 3 Trial," by Jennifer M. Mitchell, Marcela Ot'alora G., Bessel van der Kolk, Scott Shannon, Michael Bogenschutz, Rick Doblin, et al. (Nature Medicine, 2023)."MDMA Therapy Inches Closer to Approval," by Rachel Nuwer (The New York Times, 2023)."Psychedelics Reopen the Social Reward Learning Critical Period," by Romain Nardou, Edward Sawyer, Young Jun Song, Gül Dölen, et al. (Nature, 2023)."The Social Costs of Keystone Species Collapse: Evidence from the Decline of Vultures in India," by Eyal Frank and Anant Sudarshan (SSRN, 2023)."Global Health, Climate Change and Migration: The Need for Recognition of 'Climate Refugees,'" by Saverio Bellizzi, Christian Popescu, Catello M. Panu Napodano, Maura Fiamma, and Luca Cegolon (Journal of Global Health, 2023)."Comparison of Prolonged Exposure vs Cognitive Processing Therapy for Treatment of Posttraumatic Stress Disorder Among U.S. Veterans," by Paula P. Schnurr, Kathleen M. Chard, Josef I. Ruzek, et al. (JAMA Network Open, 2022)."MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study," Jennifer M. Mitchell, Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Rick Doblin, et al. (Nature Medicine, 2021)."Inner City Blues: Children Raised in Inner-Cities Face Comparable PTSD Causing Conditions and Consequences as Military Veterans and Deserve Our Attention," by Eric Citizen (SSRN, 2019)."Intergenerational Transmission of Trauma Effects: Putative Role of Epigenetic Mechanisms," by Rachel Yehuda and Amy Lehrner (World Psychiatry, 2018)."Durability of Improvement in Post-Traumatic Stress Disorder Symptoms and Absence of Harmful Effects or Drug Dependency After 3,4-Methylenedioxymethamphetamine-Assisted Psychotherapy: A Prospective Long-Term Follow-Up Study," by Michael C. Mithoefer, Mark T. Wagner, Rick Doblin, et al. (Journal of Psychopharmacology, 2013)."RETRACTED: Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ('Ecstasy')," by George A. Ricaurte, Jie Yuan, George Hatzidimitriou, Branden J. Cord, and Una D. McCann (Science, 2002).EXTRAS:"Why Aren't All Drugs Legal? (Replay)," by People I (Mostly) Admire (2022)."Can the Big Bad Wolf Save Your Life?" by Freakonomics Radio (2022)."How Are Psychedelics and Other Party Drugs Changing Psychiatry?" by Freakonomics Radio (2020).
Tired of those pesky addictive pharmaceuticals? Join us as we embark on a hopeful journey with Dr. Ben Malcolm, the Spirit Pharmacist, who's here to guide us through the critical intersection of psychedelics and traditional pharmaceutical medications. We talk in-depth about Ben's inspiring story, his extensive educational training, psychedelic integration, and how to best discontinue/taper off pills. Ben shares his vision of psychedelics being integrated into the mainstream medical model: both the wondrous possibility for healing and poignant concerns and conversations that will be paramount to the success of this movement. Show Notes Dr. Ben Malcolm We discuss; -Psychiatry's massive ethical conundrum [9:30] -Integrating these potent therapies into the mainstream model [13:00] -Dr. Malcolm's personal journey becoming the Spirit Pharmacist [18:00] -Cognitive liberty [23:00] -Harmonizing social anxiety with MDMA [26:40] -Powerful journey's with Ayahuasca and LSD [29:05] -Psychedelics for objective awareness and shifting perspective [33:00] -Psychedelic integration and the importance of practical change [39:00] -Therapy vs. Coaching [42:20] -“Best Practices” of tapering off of SSRIs [45:30] -Holistic health boosts neurotransmitters [56:00] Connect/Work with Dr. Ben Malcolm: Website: http://spiritpharmacist.com IG: https://www.instagram.com/spiritpharmacist/ FB: https://www.facebook.com/spiritpharmacist
The founder of MAPS talks about FDA approval for MDMA-assisted therapy and the "psychedelic renaissance" he has helped create.
This episode is brought to you by BiOptimizers Magnesium Breakthrough and Calm. Many people are unaware of the benefits of psychedelics when taken in a controlled, clinical setting under the care of a professional. Emerging research has shown promise for healing from trauma, connecting to your partner, and gaining insight into the bigger picture of consciousness and life itself. This week on The Dhru Purohit Podcast, Dhru sits down with Rick Doblin, Ph.D., the founder and President of the Multidisciplinary Association for Psychedelics (MAPS), to discuss the use of psychedelics, specifically MDMA, as a therapeutic intervention for qualifying candidates with complex mental illness, schizophrenia, PTSD, anxiety, eating disorders, and more. Rick Doblin, Ph.D., is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard's Kennedy School of Government, where he wrote his dissertation on regulating the medical uses of psychedelics and marijuana and his Master's thesis on smoked marijuana vs. the oral THC pill in nausea control for cancer patients. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana as prescription medicines, for the personal growth of otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. In this episode, Dhru and Rick dive into (audio version / Apple Subscriber version):-Why it's so hard to see beyond existence (1:28 / 1:28)-How Rick's beliefs and personal views were shaped by his psychedelic experiences (8:19 / 6:58)-Potential sources of inner wisdom/guidance when taking psilocybin (16:07 / 14:30)-Idiosyncrasies that caused Rick to pursue psychedelic research (28:50 / 26:42)-A deep dive into the history of MDMA (35:03 / 32:06)-Therapeutic uses of MDMA (54:20 / 57:51)-The effects of psilocybin on the brain (1:10:45 / 1:07:46)-The war on drugs and how it impacted the public's perception of psychedelics (1:20:33 / 1:17:32)-The recent advancements in psilocybin and MDMA for therapeutic use (1:27:20 / 1:24:25)-Early evidence on the ill effects of marijuana: should we be concerned? (1:30:55 / 1:28:05)-Current status of MDMA in psychological interventions (1:42 / 1:39:24)-Future hopes for FDA to allow psychedelic drugs to come to market (1:45:22 / 1:42:04)Also mentioned in this episode:-Maui Wild Fires Support/Resources-Make a donation to MAPS here -Maps.orgFor more on Rick Doblin, follow him on Instagram @rickdoblinphd.BiOptimizers is offering 10% off + special gift with purchase, just head over to magbreakthrough.com/dhru with code DHRU10.Calm is offering an exclusive offer of 40% off a Calm Premium Subscription. Head over to calm.com/dhru today. Hosted on Acast. See acast.com/privacy for more information.
Rick is the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) and has spent more than 30 years supporting psychedelic advancements. In this episode, he shares insights into his trailblazing journey and some of the exciting developments that are currently unfolding. For more information on The Great Mother's products, check out TheGreat.Mother on Instagram Check out our newly updated page instagram.com/positive_head Care to play a game with the youniverse? Ask the universe the episode you would most benefit from hearing next and click positivehead.com/game. Download The Golden Key audio or e-book at GoldenKey.Gift with the Code: POSITIVEHEAD Text Brandon to receive regular golden nuggets of wisdom at 310.564.0750
In this episode, recorded on the eve of MAPS' Psychedelic Science 2023, Kyle interviews MAPS' Founder and President, Rick Doblin, Ph.D. He begins with an overview of the fast-approaching (and largest ever) psychedelics conference, emphasizing its significant growth, many features, and bipartisan opening ceremony, then discusses MAPS' soon-to-be-released confirmatory Phase III data on MDMA-assisted therapy for PTSD, which should set the stage for legal MDMA and the increasing need for trained psychedelic therapists. As the FDA is requiring studies on adolescents, he discusses this sensitive issue and questions why it's so controversial, since teenage years are often closer to both trauma and a more malleable brain, Indigenous traditions certainly didn't have age limits, and honest drug education – something that is absolutely necessary to fight the backlash against this quickly growing field – teaches us that it's not the substance; it's our relationship to it. Could not having these rites of passage be hurting us? He also discusses the natural vs. synthetic conflict; breathwork; whether or not cannabis is truly damaging to young minds; Federal rescheduling vs. state rescheduling; why it's controversial to give therapists MDMA in training; Gul Dolen's work with reopening critical periods; psychedelics in couples therapy; and much more. Click here to head to the show notes page.
Original broadcast date: Friday, March 19, 2021. Our senses can only take us so far in understanding the world. But with the right tools, we can dig deeper. This hour, TED speakers take us through the looking glass, where we explore new frontiers. Guests include astrophysicist Emily Levesque, wildlife filmmaker Ariel Waldman, psychedelic-assisted psychotherapist Rick Doblin and science fiction author Charlie Jane Anders.TED Radio Hour+ subscribers now get access to bonus episodes, with more ideas from TED speakers and a behind the scenes look with our producers. A Plus subscription also lets you listen to regular episodes (like this one!) without sponsors. Sign-up at: plus.npr.org/ted
Rick Doblin, Ph.D., is the Founder & President of the Multidisciplinary Association for Psychedelic Studies (MAPS) and this episode is all about his life and work. This episode is a holistic look at the point where traditional therapy meets psychedelics and how Doblin and his team have spent the last few decades appealing to the scientific community and lawmakers across the world. Doblin gives us a fresh perspective on the mental health crisis discusses his studies & experiments in Iceland. We cover his early professional life and what lead him to pursue the science of alternative medicines. Doblin believes that with psychedelic assisted therapy, the world could be trauma free by 2070. Rick Doblin Links: MAPS - https://maps.org/about-maps/mission/ Get Involved - https://maps.org/take-action/ Instagram - https://www.instagram.com/rickdoblinphd/ Learn More - https://sprout.link/rickdoblinphd Please leave us a review on Apple & Spotify Podcasts. Vigilance Elite/Shawn Ryan Links: Website | Patreon | TikTok | Instagram Learn more about your ad choices. Visit podcastchoices.com/adchoices
This episode is brought to you by Rupa Health, InsideTracker, and LMNT.Compounds that have long been considered recreational drugs by conventional standards are finally being recognized through science as powerful tools for overcoming hard-to-treat health issues like PTSD, depression, addiction, and more. For the right person, psychedelics can provide a sense of peace and hope that helps heal their inner wounds and allows them to live with more freedom.In today's episode, I talk with Rick Doblin, Alberto Villoldo, and Wade Davis about the ancient healing mechanisms of plant medicine.Rick Doblin, PhD, is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in public policy from Harvard's Kennedy School of Government. His professional goals are to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist.Medical anthropologist Alberto Villoldo, PhD, is an international bestselling author who has researched the shamanic healing practices of the Amazon and Andes for over 25 years. He is the founder of the Four Winds Society, an organization dedicated to the bridging of ancient shamanic traditions with modern medicine and psychology.Wade Davis is a writer, photographer, and filmmaker. Explorer-in-Residence at the National Geographic Society from 2000 to 2013, he is currently Professor of Anthropology and the BC Leadership Chair in Cultures and Ecosystems at Risk at the University of British Columbia. He is the author of 23 books, including One River, The Wayfinders, and Into the Silence, and he was the winner of the 2012 Baillie Gifford Prize for Non-Fiction (formerly the Samuel Johnson Prize), the top nonfiction prize in the English language.This episode is brought to you by Rupa Health, InsideTracker, and LMNT. Rupa Health is a place where Functional Medicine practitioners can access more than 3,000 specialty lab tests like DUTCH, Vibrant America, Genova, and Great Plains. You can check out a free, live demo with a Q&A or create an account at RupaHealth.com.InsideTracker is offering my community 20% off at insidetracker.com/drhyman.LMNT is offering my listeners a free sample pack with any purchase. Get yours at DrinkLMNT.com/hyman today.Full-length episodes of these interviews can be found here:Rick DoblinAlberto VilloldoWade Davis Hosted on Acast. See acast.com/privacy for more information.
Rick Doblin, Ph.D., is the Founder in 1986 and President of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit that wholly owns its pharmaceutical arm, MAPS Public Benefit Corporation (PBC), which has completed two highly successful Phase 3 studies of MDMA-assisted therapy for PTSD. MAPS PBC stands at a crossroads between obtaining the additional resources it needs from philanthropy, ensuring public benefit is foremost, or becoming a publicly traded company. maps.org
This episode is brought to you by Rupa Health, Cozy Earth, Beekeeper's Naturals, and Levels. We're in the midst of a psychedelic renaissance. Compounds that have long been considered recreational drugs by conventional standards are finally being recognized through science as powerful tools for overcoming hard-to-treat health issues, like PTSD, depression, addiction, and more. Mental health problems are the number one driver of indirect healthcare costs, loss of productivity, and diminished quality of life. Yet, we aren't very successful at treating them with modern medicine. This is a pivotal moment for turning the treatment of mental health around as we explore psychedelic medicine.Today, I'm excited to talk to a leading expert and advocate in the field of psychedelic medicine, Rick Doblin. Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard's Kennedy School of Government. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. This episode is brought to you by Rupa Health, Cozy Earth, Beekeeper's Naturals, and Levels. Rupa Health is a place where Functional Medicine practitioners can access more than 2,000 specialty lab tests from over 20 labs like DUTCH, Vibrant America, Genova, and Great Plains. You can check out a free, live demo with a Q&A or create an account at RupaHealth.com.Get 40% off your Cozy Earth sheets. Just head over to cozyearth.com and use code MARK40.Beekeeper's Naturals is giving my community an exclusive offer. Just go to beekeepersnaturals.com/HYMAN and enter code “HYMAN” to get 25% off your first order.By leveraging biosensors like continuous glucose monitors, Levels provides real-time feedback on how diet and lifestyle choices impact your metabolic health. Right now you can join Levels and receive an additional two free months on your annual membership when you order at levels.link/HYMAN.Here are more details from our interview (audio version / Apple Subscriber version):Rick's early life and introduction to psychedelics (8:36 / 3:55)The history of psychedelic research and the psychedelic renaissance (30:02 / 25:24)Is psychedelic-assisted therapy practical and scalable? (32:34 / 27:55) Group and couples psychedelic-assisted therapy (36:53 / 30:40) The economics of providing psychedelic-assisted therapy (38:53 / 34:15)Drug policy reform (39:55 / 35:15) How psychedelics affect the brain (41:26 / 36:58) Reframing the public perception of psychedelics (1:02:19 / 57:50) Moving toward a world of net-zero trauma (1:04:10 / 59:30) The future of drug policy reform (1:17:47 / 1:08:50) Learn more about MAPS at maps.org. Hosted on Acast. See acast.com/privacy for more information.
© 2020-2025 Ivy Podcast Discovery LLC
